The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
The U.S. Food and Drug Administration and WebMD today announced a collaboration that expands consumers' access to the agency's timely and reliable important health information. This joint effort reflects the FDA's emphasis on using innovative, technology-based strategies to carry out its foremost mission, which is to promote and to protect the public health.
WebMD, which attracts nearly 50 million unique visitors each month, provides consumers with credible and timely health news and information.
"We are enthusiastic about this collaboration with WebMD because it will enable us to reach more consumers with accurate, science-based information that can help them improve their health," said Andrew C. von Eschenbach, M.D., commissioner of food and drugs. "This is an important step forward in our effort to form partnerships to help bring timely safety alerts and other public health information to a wider audience in the most effective and convenient way."
The partnership includes:
- A new online consumer health information resource on WebMD.com (www.webmd.com/fda): Consumers can access information on the safety of FDA-regulated products, including food, medicine and cosmetics, as well as learn how to report problems involving the safety of these products directly to the FDA. In addition, WebMD will bring the FDA public health alerts to all WebMD registered users and site visitors that request them. The cross-linked joint resource will also feature FDA's Consumer Updates—timely and easy-to-read articles that are also posted on the FDA's main consumer Web page (www.fda.gov/consumer).
- The FDA contributions to WebMD The Magazine: FDA Consumer Updates will also be featured at least three times a year in WebMD's bimonthly magazine, which reaches nearly nine million consumers. The magazine is distributed to physician office waiting rooms across the country.
For more information, please visit: http://www.fda.gov/consumer/updates/WebMD_partnership.html
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@xxxxxxxxxxx.
For additional drug information, please visit our DDI websites: http://www.fda.gov/cder/Offices/DDI/default.htm and http://www.fda.gov/cder/Offices/DDI/pathfinder.htm.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
